English

ContextVision AB presents fourth quarter and full year 2013 report

Report this content

Q4 HIGHLIGHTS

  • Governmental grant for new pilot research project, in line with growth strategy

  • New Mammo 2 product successfully launched at RSNA

  • New product configuration for Ultrasound Point-of-Care

Q4 FINANCIAL DATA

  • Sales of 15.5 MSEK (20.5)

  • Operating result of 3.7 MSEK (1.6) and operating margin of 23.7% (7.8%).

  • Earnings per share of 0,37 (0,20) SEK

A video presentation by CEO Anita Tollstadius will follow on February 21, at 09.00 CET.

Please follow the link:

webbtv.nu/contextvisionq42013

Subscribe

Documents & Links